Roche and AmorChem announce alliance focused on myotonic muscular dystrophy 1
Roche and Montreal-based venture capital firm AmorChem L.P. have entered into a collaboration to discover novel small molecule diseasemodifying therapies [Read More]
Pharmaceutical
New hope for treatment of Alzheimer’s disease
Dr. Judes Poirier from the Douglas Mental Health Institute and McGill University in Montréal (Canada) and his team say they [Read More]
MedMira’s new toolkit offers researchers speedier test results
MedMira has launched a new toolkit to accelerate the diagnostic test development process for research, academic and test developer markets. [Read More]
Synchrotron research examines novel antibiotic approach to E Coli UTIs
What began as a conversation between two animal lovers on a long horse ride turned into a successful research collaboration [Read More]
Effective In Vitro Bioanalytical Assays for Comparing Pharmacodynamics of Biosimilar Monoclonal Antibodies
Abstract The rise in the development of biosimilar therapeutics has caused increasing demand for new approaches for precise, sensitive and [Read More]
Qu Biologics announces phase 1/2 trial of treatment for Crohn’s disease
Qu Biologics is launching a phase 1/2 clinical trial to evaluate the potential clinical response and disease remission among participants [Read More]
Phase 3 study of integrase inhibitor doluegravir provides potential for HIV-1 adults who have developed resistance to antiretrovirals
ViiV Healthcare today announces 24 week data from the Phase III 48 week SAILING study evaluating the investigational integrase inhibitor [Read More]
First treatment for ultra-rare disease, aHUS, receives marketing approval in Canada
Alexion Pharma Canada announces that Health Canada has approved the use of Soliris® (eculizumab) for the treatment of patients with [Read More]
FDA Approves Longer Lengths of Medtronic’s Resolute Integrity Stent
Medtronic, Inc. announces Monday that the U.S. Food and Drug Administration (FDA) has approved the 34mm and 38mm lengths of [Read More]
Kinexus launches new antibody microarray kit
Kinexus Bioinformatics Corporation has released its first Kinex™ antibody microarray kit with its latest generation KAM-850 chip. The new antibody [Read More]
